EPIFLO^® is the first and only FDA approved therapy which uses a fully portable, 3 ounce device to deliver Oxygen to your wound 24/7. While other advanced treatment for chronic wounds exist, all have drawbacks which make them undesirable when compared with EPIFLO. Some, such as hyperbaric oxygen (HBOT), often require dozens of visits over a period of months to an enclosed, pressurized chamber for up to three times per week. Others, such as vacuum pump therapy (NPWT) require the patient to be tethered to a heavy pump 24 hours per day, often for months on end. Both of these therapies are akin to stifling a patient's freedom during the treatment, and often the wound does not heal, resulting in amputation.

NPWT seals the wound air tight and then applies negative pressure to stimulate the healing process. A published clinical review in the National Institute of Health database investigated the scientific evidence claiming the effectiveness of NPWT and concluded there was no evidence that the procedure significantly decreased the time to heal wounds compared to other treatments, and called for additional research to be done before a final determination on its effectiveness could be reached. Ogenix has published many case studies where NPWT failed to close a wound which was later closed using EPIFLO including diabetic foot ulcer with osteomyelitis, a heel pressure ulcer, and a traumatic foot injury.

A major issue with Hyperbaric Oxygen Therapy is that the patient must typically travel several times per week for a treatment that takes upwards of 90 minutes. Treatments can go on for months, causing major disruption in the patient's life. Similarly, vacuum pumps require patients to be tethered to a heavy pump 24/7. NPWT treatment can last for months, and often just reduces the size of the wound rather than close it, requiring intervention such as surgery to achieve closure.

Wound therapy using EPIFLO is different. The EPIFLO unit weighs just 3 ounces and sits in your pocket or attaches to your waistband. Once applied, you are free to go about your normal life, whether that includes shopping, dining, or even going to work. During the treatment, patients often go for up to 15 days between doctor visits, although increased drainage during the first week is a typical observation and indicates the wound is healing.

EPIFLO is disposable, and is replaced with a new unit every 15 days. Recent clinical evidence shows that the average chronic wound treated with EPIFLO heals in 6-8 weeks. Many heal faster, though some take longer. Many wounds in our database have previously failed hyperbaric or vac pump treatments before being treated with EPIFLO, and most will heal within 7 weeks in spite of failing these other treatments first.

For a risk free trial of EPIFLO, please visit our offer page.